Clinical Trial Update: Safety and Tolerability of Antiretroviral (Triumeq) in Patients With Amyotrophic Lateral Sclerosis (ALS). [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing safety and tolerability of Triumeq in patients with amyotrophic lateral sclerosis (ALS) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Triumeq (dolutegravir/abacavir/lamivudine)

Snippet

Sponsor: Neuroscience Trials Australia | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: COMPLETED